Login
Lupa
First page / Show document

Show document Help

A- | A+ | Print
Title:Endoglin (CD105) silencing mediated by shRNA under the control of Endothelin-1 promoter for targeted gene therapy of Melanoma
Authors:ID Tešić, Nataša (Author)
ID Kamenšek, Urška (Author)
ID Serša, Gregor (Author)
ID Kranjc Brezar, Simona (Author)
ID Savarin, Monika (Author)
ID Lampreht Tratar, Urša (Author)
ID Préat, Véronique (Author)
ID Vandermeulen, Gaëlle (Author)
ID Butinar, Miha (Author)
ID Turk, Boris (Author)
ID Čemažar, Maja (Author)
Files:URL http://www.nature.com/mtna/journal/v4/n5/full/mtna201512a.html
 
Language:English
Work type:Not categorized
Typology:1.01 - Original Scientific Article
Organization:FVZ - Faculty of Health Sciences
Abstract:Endoglin (CD105), a transforming growth factor (TGF)-% coreceptor, and endothelin-1, a vasoconstrictor peptide, are both overexpressed in tumor endothelial and melanoma cells. Their targeting is therefore a promising therapeutic approach for melanoma tumors. The aim of our study was to construct a eukaryotic expression plasmid encoding the shRNA molecules against CD105 under the control of endothelin-1 promoter and to evaluate its therapeutic potential both in vitro in murine B16F10-luc melanoma and SVEC4-10 endothelial cells and in vivo in mice bearing highly metastatic B16F10-luc tumors. Plasmid encoding shRNA against CD105 under the control of the constitutive U6 promoter was used as a control. We demonstrated the antiproliferative and antiangiogenic effects of both plasmids in SVEC4-10 cells, as well as a moderate antitumor and pronounced antimetastatic effect in B16F10-luc tumors in vivo. Our results provide evidence that targeting melanoma with shRNA molecules against CD105 under the control of endothelin-1 promoter is a feasible and effective treatment, especially for the reduction of metastatic spread.
Keywords:melanoma, electroporation, endoglin (CD105), endothelin-1, gene therapy
Year of publishing:2015
Numbering:No. 4
PID:20.500.12556/RUP-7057 This link opens in a new window
ISSN:2162-2531
UDC:577.2
DOI:10.1038/mtna.2015.12 This link opens in a new window
COBISS.SI-ID:1537399748 This link opens in a new window
Publication date in RUP:14.10.2015
Views:4734
Downloads:134
Metadata:XML DC-XML DC-RDF
:
TEŠIĆ, Nataša, KAMENŠEK, Urška, SERŠA, Gregor, KRANJC BREZAR, Simona, SAVARIN, Monika, LAMPREHT TRATAR, Urša, PRÉAT, Véronique, VANDERMEULEN, Gaëlle, BUTINAR, Miha, TURK, Boris and ČEMAŽAR, Maja, 2015, Endoglin (CD105) silencing mediated by shRNA under the control of Endothelin-1 promoter for targeted gene therapy of Melanoma. [online]. 2015. Vol. 4. [Accessed 13 April 2025]. DOI 10.1038/mtna.2015.12. Retrieved from: http://www.nature.com/mtna/journal/v4/n5/full/mtna201512a.html
Copy citation
  
Average score:
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica